These findings indicate that MF improves cognitive impairment through inhibiting CCH-induced gliosis, activation of NLRP3 inflammasome, and upregulation of NF-κB and STAT3. This evidence concerns the gene NFKB1 and columnar cell hyperplasia of the breast.